Novavax Inc (NVAX) USD0.01
$0.02
(0.23%)
- Add to watchlist
- This stock can be held in a
$0.02
(0.23%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
$0.02
(0.23%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
Share news, reports & tips
-
Novavax signs $1.2bn Covid-19 licensing deal with Sanofi, shares rocket
10 May 2024 11:47
(Sharecast News) - Shares of US biotech firm Novavax rocketed on Friday after it signed a $1.2bn licensing agreement with French pharmaceutical group Sanofi to commercialise its Covid-19 vaccine from next year.
-
Novavax to cut global workforce by a quarter
9 May 2023 13:13
(Sharecast News) - Novavax is to cut a quarter of its workforce and slash spending, the US biotech said on Tuesday, as it looks to manage costs amid waning demand for its Covid vaccine.
-
Novavax Covid vaccine approved for use in the UK
3 February 2022 14:06
(Sharecast News) - The UK has approved Novavax's Covid-19 vaccine for use in adults, the medicines regulator confirmed on Thursday.
Company announcements Announcements
No company announcements about Novavax Inc USD0.01 were found.
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2024. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.